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Hypoxia, Not the Frequency of
Sleep Apnea, Induces Acute Hemodynamic
Stress in Patients With Chronic Heart Failure
Joshua D. Gottlieb, AM,* Alan R. Schwartz, MD,† Joanne Marshall,‡ Pamela Ouyang, MBBS,†
Linda Kern,† Veena Shetty, MPH,§ Maria Trois,† Naresh M. Punjabi, MD, PHD,†
Cynthia Brown, MD, Samer S. Najjar, MD,¶ Stephen S. Gottlieb, MD‡
Cambridge, Massachusetts; Baltimore, Maryland; and Charlottesville, Virginia
Objectives This study was conducted to evaluate whether brain (B-type) natriuretic peptide (BNP) changes during sleep are
associated with the frequency and severity of apneic/hypopneic episodes, intermittent arousals, and hypoxia.
Background Sleep apnea is strongly associated with heart failure (HF) and could conceivably worsen HF through increased
sympathetic activity, hemodynamic stress, hypoxemia, and oxidative stress. If apneic activity does cause acute
stress in HF, it should increase BNP.
Methods Sixty-four HF patients with New York Heart Association functional class II and III HF and ejection fraction 40%
underwent a baseline sleep study. Five patients with no sleep apnea and 12 with severe sleep apnea underwent
repeat sleep studies, during which blood was collected every 20 min for the measurement of BNP. Patients with
severe sleep apnea also underwent a third sleep study with frequent BNP measurements while they were admin-
istered oxygen. This provided 643 observations with which to relate apnea to BNP. The association of log BNP
with each of 6 markers of apnea severity was evaluated with repeated measures regression models.
Results There was no relationship between BNP and the number of apneic/hypopneic episodes or the number of arous-
als. However, the burden of hypoxemia (the time spent with oxygen saturation 90%) significantly predicted
BNP concentrations; each 10% increase in duration of hypoxemia increased BNP by 9.6% (95% confidence inter-
val: 1.5% to 17.7%, p  0.02).
Conclusions Hypoxemia appears to be an important factor that underlies the impact of sleep abnormalities on hemodynamic
stress in patients with HF. Prevention of hypoxia might be especially important for these patients. (J Am Coll
Cardiol 2009;54:1706–12) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.08.016t
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ileep apnea has been strongly associated with heart failure
HF) in various cross-sectional studies, with a reported
revalence as high as 40% in HF patients (1,2). Although
rom *Harvard University, Cambridge, Massachusetts; †Johns Hopkins Bayview
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ttp://nihroadmap.nih.gov/clinical research/overview-translational.asp. This study was
upported, in part, by the Intramural Research Program of the National Institute on
ging, NIH, a portion of which was through a Research and Development Contract
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Manuscript received June 26, 2009; revised manuscript received August 26, 2009,
ccepted August 30, 2009.he extent to which sleep apnea reflects HF severity or
auses worsening HF is controversial, there are suggestions
hat sleep apnea can be harmful. Heart failure patients with
leep apnea have a worse prognosis than do patients without
leep apnea (3,4), and treating sleep apnea can improve
emodynamics, alleviate cardiovascular stress, and poten-
ially prolong survival in HF patients (5,6).
See page 1713
The hallmark of sleep apnea is recurrent episodes of
ypoxemia and arousals throughout the night. These arous-
ls are accompanied by bursts of sympathetic stimulation
hat elicit peripheral vasoconstriction and an increase in
eart rate and blood pressure (7). Furthermore, the mechan-
cal stresses in obstructive sleep apnea can lead to an increase
n left ventricular afterload with further compromise of
ardiac output (8). Hypoxia itself can have direct detrimen-
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October 27, 2009:1706–12 Sleep Apnea and Hemodynamic Stressal cardiac effects (9). Thus, increased sympathetic activity,
emodynamic stress, and hypoxia could all potentially cause
xacerbation of HF.
Brain (B-type) natriuretic peptide (BNP) is a polypeptide
ith a short half-life (20 min) that is secreted by the
entricles in response to cardiomyocycte stretching, and thus is
good marker of hemodynamic stress. If apneic episodes cause
cute stress in patients with HF, then BNP levels would be
xpected to rise and fall contemporaneously. We hypothesized
hat in patients with HF, the changes in the concentrations of
NP during the night are associated with the frequency of
pneic/hypopneic episodes and arousals, as well as the severity
f hypoxemia. To address these hypotheses, we designed a
tudy that could evaluate the immediate effects of sleep distur-
ances on BNP by measuring BNP levels every 20 min during
leep and characterizing the sleep and breathing patterns
uring these same 20-min blocks.
ethods
tudy Design
atient selection. Subjects were recruited from the patient
opulations at Johns Hopkins Bayview Medical Center and
he University of Maryland. All patients had stable symp-
omatic HF and a left ventricular ejection fraction 40%.
hey were euvolemic and on a stable HF medication
egimen for at least 1 month. Patients were excluded if they
ad unstable angina, myocardial infarction, or hospitaliza-
ion within the previous 2 months.
tudy protocol. Patients underwent 3 nights of study. On
ight 1 (baseline test), patients were acclimatized to the
leep laboratory and underwent a standard sleep study to
haracterize their sleep and breathing patterns. Baseline
ecordings were analyzed to categorize patients into 1 of 3
roups: no or mild sleep apnea present, overall apnea-
ypopnea index (AHI) 5; sleep apnea of intermediate
everity, AHI 6 to 39.9; or severe sleep apnea, AHI 40.
Patients with no to mild sleep apnea and patients with
evere sleep apnea were selected for further study to examine
he effects of apnea on BNP. They subsequently underwent
second sleep study, now with blood sampling every 20
in. (We refer to each sampling interval as an “epoch.”)
atients with intermediate sleep apnea were not further
tudied because we desired to maximize our sensitivity to
etect significant effects of sleep apnea on BNP. Those
atients with intermediate sleep apnea were similar to the
atients who underwent blood sampling (Table 1).
After at least 2 weeks, patients with severe sleep apnea
nderwent a third sleep study with frequent blood sampling
nd also with administration of supplemental oxygen (in-
ervention night). The data from the 2 nights with frequent
lood sampling obtained from subjects with severe sleep
pnea together with the 1 night of blood sampling obtained
rom subjects with no or mild sleep apnea on the baseline
est form the basis of the present study. (Note that some of
he subjects without sleep apnea on baseline testing had (ild or moderate sleep apnea on
epeat testing; the group with
HI 5 on baseline testing is
eferred to as mild sleep apnea
hroughout this paper).
By comparing the BNP ob-
ained during the normal sleep
pochs with the BNP obtained
uring epochs with sleep abnor-
alities, the multiple time points
rovide the power to look at the
mmediate effects of apneic epi-
odes, arousals, and hypoxia on
NP. We evaluated 12 HF pa-
ients with severe sleep apnea,
oth with and without supple-
ental oxygen, and 5 HF pa-
ients with mild to moderate sleep apnea on the baseline
est. This provided 643 time-series measurements of BNP
evels and apnea counts.
leep recording methods. Standardized recording meth-
ds were utilized as previously described (10) and included
ontinuous monitoring of left and right electro-oculogram,
ubmental electromyogram, C3 to A2 and C3 to O1 elec-
roencephalogram, anterior tibialis electromyogram, orona-
al airflow as assessed by both a pressure-sensitive nasal
annula and a thermistor, pulse oximetry, and thoracic and
bdominal movements with piezo-electric gauges, and a
odified V5 electrocardiography lead for cardiac rhythm
onitoring. Patients were admitted to the unit at 5:00 PM
or the sleep study. Thereafter, a standardized meal was
rovided for dinner at 6:00 PM. Sleep study recording
ensors were applied, and a forearm intravenous catheter
Abbreviations
and Acronyms
AHI  apnea-hypopnea
index
BNP  brain (B-type)
natriuretic peptide
CSA  central sleep apnea
HF  heart failure
OSA  obstructive sleep
apnea
SaO2  oxygen saturation
t90  percentage of time
spent during each epoch at
oxygen saturation levels
<90%
aseline Characteristics of Subjects Found to Haveoderate Sleep Apnea, Mild (or No) Sleep Apne ,nd Severe Sl ep Apnea n Bas line t dy*
Table 1
B seline Characteristics of Subjects Found to Have
Moderate Sleep Apnea, Mild (or No) Sleep Apnea,
and Severe Sleep Apnea on Baseline Study*
Moderate
Sleep Apnea
(n  47)
Mild
Sleep Apnea
(n  5)
Severe
Sleep Apnea
(n  12)
Age, yrs 59 12 56 12 61 13
Sex, male 36 (76%) 3 (60%) 11 (92%)
Race, African-American 11 (23%) 1 (20%) 4 (33%)
Ejection fraction, % 20 7 25 6 19 4†
Cardiomyopathy, ischemic 26 (55%) 2 (40%) 6 (50%)
Heart rate, min1 68 9 76 12 64 11†
Body mass index, kg/m2 32 7 32 7 34 8
Prescribed medications
Beta-blockers 63 (97%) 5 (100%) 12 (100%)
ACE inhibitors or ARB 45 (95%) 5 (100%) 12 (100%)
Loop diuretic 41 (87%) 4 (80%) 10 (83%)
BNP prior to sleep, pg/ml 85 90 243 469
Patients with moderate sleep apnea did not have subsequent study days with blood sampling.
p 0.05 patients with severe sleep apnea compared with patients who had mild sleep apnea on
aseline study.
ACE  angiotensin-converting enzyme; ARB  angio
B-type) natriuretic peptide.
tensin receptor blocker; BNP  brain
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Sleep Apnea and Hemodynamic Stress October 27, 2009:1706–12as placed. The sleep study commenced at 10:00 PM (lights
ut) and ended at 6:00 AM the next morning.
requent venous sampling protocol. Venous blood was
rawn every 20 min for BNP. An initial baseline sample
as drawn at 10:00 PM at “lights out.” The next sample was
rawn at 10:40 PM and every 20 min thereafter until 6:00
M. The values recorded during the initial 40-min epoch of
ll data that are recorded in the form of counts per epoch are
eflated by 50% to make the frequencies comparable to
hose recorded during subsequent 20-min epochs.
nalytic Methods
leep study analysis. Standard methods for evaluating
leep structure and respiratory patterns were applied to all
leep study recordings and are detailed in the Online
ppendix.
ssays. Samples were spun down and stored at 70°C.
he BNP (pg/ml) was assayed by radioimmunoassay (fluores-
ence immunoassay, Biosite, Inc., San Diego, California).
rimary analysis. We used the data to look for an associ-
tion between apnea episodes and BNP concentrations over
he time the subjects were observed. With 17 subjects, 11 of
hom were monitored for 2 nights, and 23 observations per
atient per night (except for 1 patient who had 1 less
bservation), we have 643 observations with which to relate
pnea to BNP. (Blood testing was not performed on 1 of the
2 treatment subjects during the intervention night, so no
NP data are available for this subject for that night.) For
ach observation, we can relate the BNP concentration to
leep-disordered breathing exposure over the preceding
0-min epoch. To account for differences between treat-
ent and nontreatment nights, different nights on which
he same subject was observed are treated as independent
bservations.
In the primary analyses, we modeled the contemporane-
us effects of sleep-disordered breathing activity on BNP.
ur major predictor variables consisted of measures of
leep-disordered breathing severity. These metrics included
he number of disordered breathing episodes (total, central,
nd obstructive), the number of arousals, and the severity of
xyhemoglobin desaturation during each 20-min epoch.
he severity of intermittent desaturation was reflected by
he average difference in oxygen saturation (SaO2) from the
tart to the end of each sleep-disordered breathing episode
average low SaO2). The overall severity of hypoxemia was
epresented by the percentage of time spent during each
0-min epoch at SaO2 levels 90% (t90).
The fundamental challenge in analyzing these relation-
hips is that multiple factors might cause changes in both
NP and apnea characteristics. With repeated measure-
ents of BNP and the independent variables throughout
he night, however, we can detect a relationship while
ccounting separately for variations across individual sub-
ects and variations over time. We use a variety of standard
ime-series regression techniques to accomplish this. dupplementary analyses. Because BNP remains in the
lood after release by the left ventricle (with a half-life of
pproximately 20 min), and also because apneas could
heoretically have a cumulative effect on hemodynamic
tress, we investigated the possibility that apneas during a
revious epoch may affect the level of BNP measured
ubsequently. We did this by adding 5 lags of the indepen-
ent variable in our regressions, as shown in the Appendix
quation (2). This allows us to measure the effect of apneas
uring the most recent epoch as well as the 5 previous
0-min periods on the current level of BNP. We are,
herefore, able to detect the effect of 2 h worth of apneas on
NP. Further details are in the Online Appendix.
We conducted an additional analysis to distinguish be-
ween the effects of hypoxia associated with central sleep
pnea (CSA) and hypoxia associated with obstructive sleep
pnea (OSA). We first separated the 643 epochs based on
he prevalence of the different types of apneas. We elimi-
ated the 78 epochs with no sleep apneas and separated the
emaining 565 epochs into 2 categories: predominantly
SA epochs were those in which at least one-half of the
pneas were central (192 epochs); the remainder were
onsidered predominantly OSA epochs.
Any difference between the impact of CSA-associated
ypoxia on BNP and the impact of OSA-associated hypoxia
n BNP should show up when we distinguish the frequency
f hypoxemia during predominantly CSA epochs from the
requency during predominantly OSA epochs. We therefore
an a multivariate regression of log BNP on 2 separate
ypoxemia variables. The first variable is equal to the
ercent of time during each predominantly CSA epoch that
as spent with SaO2 90%, and it is equal to zero for all
redominantly OSA epochs. Similarly, the second variable
s equal to the percent of time that was spent with SaO2
90% during predominantly OSA epochs. As in Table 3,
e ran a fixed-effects regression with clustered standard
rrors.
After the primary and secondary analyses discussed above,
e checked the robustness of our general pattern of negative
esults to various changes in the model specification. The
escription of these analyses and the results are in the
nline Appendix.
esults
he characteristics of the patients studied are described in
able 1. The patients with severe sleep apnea had a lower
jection fraction and a slower heart rate compared with
atients who had mild sleep apnea.
The sleep study results are shown in Table 2. By design,
he patients with severe apnea had more severe apneic and
ypoxic parameters than did patients who had mild sleep
pnea in the baseline study. These parameters were allevi-
ted by supplementation of oxygen (night 3) compared with
he study without an intervention (night 2). As previously
escribed, oxygen led to a modest reduction in AHI (11)
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October 27, 2009:1706–12 Sleep Apnea and Hemodynamic Stressnd an increased proportion of obstructive, compared with
entral and mixed apnea (12).
Figure 1 illustrates the time course of mean BNP and
ypoxemia in each 20-min period through the night for all
atients. At each time point, the percentage of time for that
poch spent with SaO2 90% (t90) is shown (dashed line).
he values in the graph are the means for all patients.
imilarly, the mean BNP concentrations for all patients are
hown. Overall, no progressive change in BNP is detected
ver time. However, the individual fluctuations of BNP at
arious time points appear to coincide with t90.
Figure 2 demonstrates the time course of BNP (as
escribed in the preceding text) and the number of sleep-
leep Study Results of Patients With Mild Sleeppnea at Baseline (Mild Sleep Apnea) an Thoseith Severe Sleep Apnea Without (Night 2) and(Night 3) Oxyge Supplementat on
Table 2
Sleep Study Results of Patients With Mild Sleep
Apnea at Baseline (Mild Sleep Apnea) and Those
With Severe Sleep Apnea Without (Night 2) and
With (Night 3) Oxygen Supplementation
Mild
Sleep Apnea
Severe
Sleep Apnea
Night 2
Severe
Sleep Apnea
Night 3
(With O2)
Total apnea-hypopnea index 16 8 66 31 48 18*
Percent obstructive apneas 93 8 57 37 74 34*
Percent central apneas 2.2 1.8 18 25 15 27
Percent mixed apneas 4.3 7.4 26 22 11 14*
Total arousal index, n/h 13 8 47 23 39 21
t90, % 0.49 0.60 15.2 19.6 1.7 3.6*
Baseline SaO2 96.9 1.4 96.0 2.0 98.1 0.8*
Average low SaO2, % 93.6 2.0 88.9 4.4 94.7 2.4*
Baseline log BNP 3.5 2.1 3.6 2.6 4.5 1.3
Mean log BNP 3.9 1.3 3.5 2.5 4.5 1.4
p  0.05 night 3 versus night 2. Note that patients in the mild sleep apnea group had mild or no
leep apnea on the baseline study, but may have had mild to moderate sleep apnea on the
ubsequent study. Mean log brain (B-type) natriuretic peptide (BNP) refers to the mean of all
amples obtained through the night.
SaO2 oxygen saturation; t90 percentage of epoch spent at oxygen saturation levels90%.
Figure 1 Mean BNP and t90
For each time point through the night, the mean brain (B-type) natriuretic pep-
tide (BNP) of all patients (solid line) and the percentage of time with oxygen
saturation 90% (t90) (dashed line) are shown. Note that the BNP appears to
fluctuate with the extent of hypoxemia.iisordered breathing episodes in each 20-min period
hrough the night for all patients. There is no relationship
etween the number of sleep-disordered breathing episodes
t each time point and the change in BNP.
The results of the primary regressions are presented in
able 3. Each row of the table shows the relationship
etween a different independent variable and the logarithm
f BNP, controlling for a linear time trend and individual
xed effects. There was minimal effect of the number of
pisodes on BNP. However, the impact of hypoxemia is
mphasized by the relationship of BNP concentration to
oth t90 and the difference in SaO2 between the start and
nd of each sleep-disordered breathing episode.
The point estimates of BNP responses to sleep-
isordered breathing frequency parameters are small, not
ignificant, and are neither consistently positive nor negative
Table 3). For example, the coefficient on the total number
f apneas (regression 1) is only 0.002. The standard errors
re small enough that we can say with 95% certainty that the
rue coefficient is 0.0104. Interpreting this clinically, 10
pneas in 20 min—or 30 apneas/h—would increase BNP
y 10.4%. The coefficients on the other independent
pnea variables are also precisely estimated to be close to
ero. Even obstructive apneas (regression 3), which would
e expected to cause elevations in BNP from hemodynamic
tress, have a point estimate of 0.0037 and an upper bound
f 0.0168. Thus, 30 extra obstructive apneas/h would
ncrease BNP at the most by 16.8%.
In contrast to the frequency of sleep-disordered events,
octurnal hypoxemia predicts elevations in BNP. The t90
as a significant positive coefficient of 0.0096, meaning that
n extra 10% of the epoch (i.e., 2 min) at low oxygenation
Figure 2 Mean BNP and Frequency of
Sleep-Disordered Breathing Episodes
For each time point through the night, the mean brain (B-type) natriuretic pep-
tide (BNP) of all patients (solid line) and the frequency of sleep-disordered
breathing episodes (dashed line) are shown. Note that the BNP does not
appear to fluctuate with the frequency of sleep-disordered breathing episodes.ncreases BNP by 9.6%, with an upper bound of 17.7% and
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Sleep Apnea and Hemodynamic Stress October 27, 2009:1706–12lower bound of 1.5%. A similar effect of intermittent
esaturation (regression 6) on BNP was observed. Although
ot statistically significant, the coefficient of 0.0169 indi-
ates that an extra 10 percentage points of average saturation
ifference increases BNP by 16.9% (95% confidence inter-
al: 10.0% to 43.9%).
We did not detect any significant differences in BNP
etween nights 2 and 3. The power to compare BNP on
ight 2 and night 3 is limited by the lack of randomization
nd the small number of patients. Indeed, baseline log BNP
before oxygen was administered) on night 3 was elevated
ompared with night 2 (Table 2).
econdary analyses. There was no latency to a BNP
esponse. The number of sleep-disordered breathing epi-
odes in the preceding 1, 2, 3, 4, or 5 20-min epochs did not
redict log BNP (Online Appendix Table 3). Similarly, t90
n preceding epochs generally did not predict log BNP,
uggesting that BNP rose contemporaneously with hypoxic
xposure (Online Appendix Table 4).
The results of the analysis comparing the effects of central
nd obstructive sleep apnea are as follows:
og BNP 0.0075[0.0013 to 0.0164]
 predominantly CSA hypoxemia
 0.0089[0.0038 to 0.0217]
 predominantly OSA hypoxemia
The brackets after each coefficient show 95% confidence
ntervals. A t test for equality of the 2 coefficients is unable
o reject equality (p  0.85). Thus, it appears that hypox-
mia associated with CSA has the same impact on BNP as
ypoxemia associated with OSA.
iscussion
he present study found that in patients with stable HF,
hanges in BNP during the night were related to the
everity of nocturnal hypoxemia, but not to the frequency or
ype of sleep-disordered breathing episodes or associated
rousals. Mechanical and neurohormonal effects of sleep-
isordered breathing might be expected to produce hemo-
Effect of Apneas on BNPTable 3 Effect of Apneas on BNP
Regression Independent Vari
Frequency parameters
1 Total number of apneas an
2 Number of central apneas
3 Number of obstructive apn
4 Number of arousals
Desaturation parameters
5 Percent with O2 saturation
6 Average difference betwee
nadir of O2 saturation
Each row reports the result of a separate regression of the logarithm of
Standard errors are clustered by patient-night, of which there were 28
and a linear time trend. The sample size is n  643 for each regressiynamic stress. Nevertheless, intensive sampling of BNP ahowed no relationship between BNP and the frequency of
leep-disordered breathing events or arousals. In contrast,
he severity of hypoxemia (defined as percentage of time
ith an oxygen saturation 90%) did appear to correlate
ith increased BNP. Few previous studies have separated
ypoxia from nonhypoxic arousals and obstruction, and our
ndings show divergent effects of hypoxic and nonhypoxic
pisodes. This suggests that sleep-disordered breathing may
e detrimental in HF because of hypoxia exerting adverse
ffects.
emodynamic effects of sleep apnea. The interaction
etween HF and sleep apnea is bidirectional. Hemodynamic
isturbances associated with left ventricular dysfunction
redispose to periodic breathing and a worsening of sleep
pnea (13,14), but there is also evidence that sleep apnea
xacerbates HF, and treatment can improve outcomes (5,6).
lthough apnea has hemodynamic consequences, it is
nclear whether these adverse cardiac sequelae are due to
he hypoxia that is associated with the apnea or to the direct
emodynamic effects of the apneas.
Upper airway obstruction does increase cardiac pre-load
nd afterload when dogs inspire repeatedly against an
ccluded upper airway, but these effects are transient and
issipate during expiration. Perhaps more important are the
ndings that arousals can exacerbate left ventricular dys-
unction by their effects on sympathetic drive, arterial
asoconstriction, and blood pressure (15). Similarly, sleep
pnea is associated with recurrent nocturnal surges in blood
ressure after each apnea cycle (16). These findings could be
econdary to either direct hemodynamic effects or hypoxia.
hile sleep apnea is clearly associated with hemodynamic
hanges, the present study suggests that the acute hemody-
amic effects of obstructive apnea do not cause elevations in
NP.
ardiovascular effects of hypoxia. In contrast to the lack
f impact of apnea or arousal frequency on BNP, the
elationship with hypoxia suggests that mechanisms caused
y hypoxia impact cardiovascular function and stress. There
s growing evidence that hypoxia is the cause of the
ardiovascular effects of sleep apnea. In anesthetized dogs
Coefficient 95% Confidence Interval
pneas 0.0020 [0.0064–0.0104]
0.0014 [0.0185–0.0156]
0.0037 [0.0094–0.0168]
0.0033 [0.0138–0.0072]
0.0096 [0.0015–0.0177]*
and 0.0169 [0.0100–0.0439]
-type) natriuretic peptide (BNP) on the independent variable specified.
t observations. Every regression also includes individual fixed effects
0.02.able
d hypo
eas
90%
n peak
brain (Bnd sedated pigs, investigators have found that the hemo-
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October 27, 2009:1706–12 Sleep Apnea and Hemodynamic Stressynamic sequelae of sleep apnea are related to the severity of
xyhemoglobin desaturations during apneic episodes (17).
he mechanisms might include the negative inotropic effect
f hypoxia (18) or the sympathetic drive caused by hypoxia.
ypoxia impairs contractility by altering the action poten-
ial which, in turn, interferes with excitation-contraction
oupling (19). Hypoxia also leads to a rise in intracellular
odium and calcium, which can be deleterious to the
yocytes. Interestingly, in single adult rat myocytes, mod-
rate hypoxia may cause earlier calcium loading and more
rogressive cell destruction than complete anoxia (20).
ypoxia leads to increased sympathetic activity and arousals
t the termination of apneic episodes (21). Moreover,
entral autonomic responses to intermittent hypoxemia and
rousal overwhelm local vasodilatory responses and trigger
ronounced sympathetic neural discharge, peripheral vaso-
onstriction, and increases in blood pressure and cardiac
fterload (19).
The association of sleep apnea and hypertension may also
e related to hypoxia, rather than arousals. While recurrent
rousals increase blood pressure acutely after apneic epi-
odes, blood pressure remains elevated during wakefulness
nly when nocturnal intermittent hypoxemia is superim-
osed (22). Indeed, intermittent hypoxemia in combination
ith arousals may be responsible for the finding in humans
hat sympathetic nerve activity is elevated in apneic patients
ompared with weight-, age-, and sex-matched controls (23).
Repeated cycles of hypoxemia followed by reoxygenation
riggers the generation of reactive oxygen species and
ncreases oxidative stress (24,25), which, in turn, induces the
elease of inflammatory cytokines (e.g., tumor necrosis
actor-) (26). These alterations may, in the long term,
xacerbate left ventricular dysfunction.
iomarkers of cardiovascular stress in HF and sleep
pnea. BNP, a noninvasive marker of cardiovascular stress,
eflects the hemodynamic status and prognosis of HF
atients. Numerous studies have demonstrated the relation-
hip between BNP and HF severity (27). Importantly, BNP
an acutely reflect changes in hemodynamics. For example,
t closely tracked improvement in the pulmonary arterial
edge pressure when HF patients were treated for pulmo-
ary edema (28).
Previous studies of sleep apnea patients suggest that
atriuretic peptide concentrations might be affected by sleep
pnea and may be impacted by treatment (29–31). In a very
mall study, OSA appeared to increase atrial natriuretic
eptide overnight, but not BNP (32). In contrast, in 22
hildren, BNP increases overnight correlated with AHI
33). Supporting the findings of the present study,
ypoxemia increased the levels of N-terminal proBNP in
ealthy young men (34), and oxygen therapy decreased
NP concentrations in HF patients with CSA (35).
hese studies, however, did not look at the cause of
ecreases in BNP.onclusions
ur findings suggest that hypoxia is an important factor in
he impact of sleep abnormalities in patients with HF. The
resent study does not identify whether hypoxia mediates
NP release through direct effects on cardiac contractility,
ympathetic nervous system activation, oxidative stress, or
ther unknown mechanisms. However, the finding that
cute changes in BNP are associated with hypoxia rather
han apneic episodes suggests a mechanism for the associ-
tion of sleep abnormalities with HF. Prevention of hypoxia
ight be especially important in patients with sleep-
isordered breathing and HF. A larger sample size and
andomized study design will be required to test this
ypothesis.
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APPENDIX
or the standard methods of evaluating sleep structure and respiratory
atterns that were applied to all sleep study recordings, please see the
nline version of this article.
